Pradžia › Krono liga
Krono liga klinikiniai tyrimai JAV ieško dalyvių
93 tyrimai dėl Krono liga ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- New York City, NY35 tyrimai
- Cleveland, OH19 tyrimai
- St. Louis, MO19 tyrimai
- Boston, MA19 tyrimai
- Miami, FL19 tyrimai
- Orlando, FL17 tyrimai
- Houston, TX17 tyrimai
- Atlanta, GA17 tyrimai
- Tyler, TX16 tyrimai
- San Diego, CA15 tyrimai
- San Antonio, TX15 tyrimai
- Los Angeles, CA15 tyrimai
- Philadelphia, PA13 tyrimai
- Colorado Springs, CO13 tyrimai
- Durham, NC12 tyrimai
- Providence, RI12 tyrimai
- Tacoma, WA11 tyrimai
- Pittsburgh, PA11 tyrimai
- Cincinnati, OH11 tyrimai
- Seattle, WA11 tyrimai
- Baltimore, MD10 tyrimai
- Washington, DC10 tyrimai
- Indianapolis, IN10 tyrimai
- Dallas, TX10 tyrimai
- Lubbock, TX10 tyrimai
- Tampa, FL10 tyrimai
- Ann Arbor, MI9 tyrimai
- Chicago, IL9 tyrimai
- Louisville, KY9 tyrimai
- Evanston, IL9 tyrimai
- Lewisville, TX9 tyrimai
- Rochester, MN8 tyrimai
- Parma, OH8 tyrimai
- New Haven, CT8 tyrimai
- Columbus, OH8 tyrimai
- Charlotte, NC8 tyrimai
- Independence, MO8 tyrimai
- Milwaukee, WI7 tyrimai
- Lafayette, LA7 tyrimai
- Queens, NY7 tyrimai
Pagal valstiją
- Aidahas4 tyrimai
- Ajova8 tyrimai
- Alabama9 tyrimai
- Arizona17 tyrimai
- Arkansas3 tyrimai
- Džordžija22 tyrimai
- Florida27 tyrimai
- Ilinoisas18 tyrimai
- Indianas13 tyrimai
- Kalifornija37 tyrimai
- Kanzasas11 tyrimai
- Kentukis12 tyrimai
- Koloradas18 tyrimai
- Kolumbijos apskritis4 tyrimai
- Konektikutas14 tyrimai
- Luiziana11 tyrimai
- Masčusetsas27 tyrimai
- Merilendas15 tyrimai
- Minesota11 tyrimai
- Misisipė3 tyrimai
- Misūris21 tyrimas
- Mičiganas20 tyrimai
- Naujoji Hampšyras3 tyrimai
- Nevada8 tyrimai
- New Jersey9 tyrimai
- New York36 tyrimai
- North Carolina20 tyrimai
- Ohio30 tyrimai
- Oklahoma8 tyrimai
- Oregon4 tyrimai
- Pennsylvania23 tyrimai
- Rhode Island12 tyrimai
- South Carolina11 tyrimai
- South Dakota4 tyrimai
- Tennessee10 tyrimai
- Texas35 tyrimai
- Utah8 tyrimai
- Virginia15 tyrimai
- Washington22 tyrimai
- Wisconsin7 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07619547Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Renkami dalyviai3 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2026-10-02 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07697456Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07033208Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07852273A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Renkami dalyviai4 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06581328Non-nutritive Sweeteners in Inflammatory Bowel Disease
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07769437A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-25 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07196722A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Renkami dalyviai3 fazė
Amžius 3 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06663332A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937099Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
Renkami dalyviai
Amžius nuo 16 iki 75 · Visoms lytims · Atnaujinta 2026-09-24 · NCT07671872Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-23 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Renkami dalyviai2 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Renkami dalyviai3 fazė
Amžius nuo 2 iki 19 · Visoms lytims · Atnaujinta 2026-09-22 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Renkami dalyviai4 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-09 · NCT06045754Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.